UK Medtech Hopes For 'Just-In-Time' Delivery Of Brexit Clarity
Executive Summary
The UK medtech sector is desperate for substantive information about what is expected of them and how they should proceed as the threat of a no-deal Brexit lingers, says Richard Phillips, who runs policy operations for trade group ABHI. Will the October EU Council meeting provide answers?
You may also be interested in...
Brexit No Certain Thing For European Medtech Groups Desperate To Plan Futures
Medtech stakeholders were reminded at the UK's largest regulatory forum that, for business in general, and medical technology manufacturers in particular, those willing to make the best of Brexit are still having to work in the dark. The lack of useful government outreach is frustrating most efforts to secure business continuity. And that is without factoring in the huge regulatory changes that the EU's twin medical device regulations – the MDR and IVDR – will bring.
Brexit + MDR Equals Little Certainty For UK And EU Medtech Groups
Medtech stakeholders were reminded recently at the UK's largest regulatory forum that even those willing to make the best of Brexit are still working in the dark. The lack of useful government outreach is frustrating most efforts to secure business continuity. And that is without factoring in the huge regulatory changes that the EU's twin medical device regulations – the MDR and IVDR – will bring.
Pressing Timetable For UK Facing No-Deal Brexit Risk, More Technical Notices And Committee Work
The path of Brexit is not running smoothly for the UK in its negotiations with the EU on a withdrawal agreement featuring a free trade deal. Opportunities for these negotiations are running out. At home, the UK government has issued more "no deal" technical notices, and continues to run a busy parliamentary Brexit committee schedule.